UPB
Upstream Bio, Inc.
NASDAQ · USHealthcareBiotechnology
$6.83-2.50%
Price as of Jul 20, 2026
UPB earnings
Upstream Bio, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 5, 2026in NaN days
EPS est $-0.78 · Revenue est $431143
Track record
Beat EPS in 1 of 5 quarters
Avg surprise -43.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 13, 2026 | $-0.74 | $-0.75 | -1.2% | $1M | +0.6% |
| Mar 26, 2026 | $-0.73 | $-0.79 | -8.2% | $668000 | +14.4% |
| Nov 5, 2025 | $-0.78 | $-0.63 | +19.2% | $683000 | +31.0% |
| Mar 13, 2025 | $-0.56 | $-1.59 | -183.9% | $613000 | +87.9% |
| Nov 7, 2024 | $-0.54 | $-6.96 | -1200.3% | $607000 | +52.8% |
| Dec 31, 2023 | — | $-0.14 | — | $2M | — |
| Sep 30, 2023 | — | $-0.09 | — | $621000 | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-05.